ArteraAI Stock

HealthTech

Developer of AI-enabled predictive and prognostic cancer tests designed to identify patients who will benefit from therapy intensification. The company's tests leverage an algorithm that assesses digital images from a patient's biopsy and learns from a patient's clinical data, enabling clinicians with more information to make informed treatment decisions.